Alterations of leptin in the course of inflammation and severe sepsis

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Behnes, Michael ^a   Brueckmann, Martina ^a   Lang, Siegfried ^a   Putensen, Christian ^b   Saur, Joachim ^a   Borggrefe, Martin ^a   Hoffmann, Ursula ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Adipocytes; Drotrecogin alpha (activated); Leptin; mRNA; Sepsis; Supernatants

Indexed keywords

DROTRECOGIN; LEPTIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEPSIS; SUPERNATANT; UPREGULATION;

ADIPOCYTES; ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; LEPTIN; MALE; MIDDLE AGED; PROTEIN C; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SEPSIS; SERUM; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME;

EID: 84866171025     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-217     Document Type: Article

References (46)

1. Trayhurn P, Wood IS. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355. 10.1079/BJN20041213, 15469638.
2. Lago F, Dieguez C, Gomez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 2007, 18:313-325. 10.1016/j.cytogfr.2007.04.007, 17507280.
3. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115:911-919. quiz 920, 10.1016/j.jaci.2005.02.023, 15867843.
4. Otero M, Lago R, Gomez R, Dieguez C, Lago F, Gomez-Reino J, Gualillo O. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford). 2006, 45:944-950.
5. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The accp/sccm consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
6. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 sccm/esicm/accp/ats/sis international sepsis definitions conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B, 12682500.
7. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the united states: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002, 11445675.
8. Angus DC, Pereira CA, Silva E. Epidemiology of severe sepsis around the world. Endocr Metab Immune Disord Drug Targets. 2006, 6:207-212.
9. Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR. Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure. Crit Care Med 2005, 33:341-348. 10.1097/01.CCM.0000153520.31562.48, 15699837.
10. Koch A, Weiskirchen R, Zimmermann HW, Sanson E, Trautwein C, Tacke F. Relevance of serum leptin and leptin-receptor concentrations in critically ill patients. Mediators Inflamm 2010, pii:473540.
11. Yousef AA, Amr YM, Suliman GA. The diagnostic value of serum leptin monitoring and its correlation with tumor necrosis factor-alpha in critically ill patients: A prospective observational study. Crit Care 2010, 14:R33. 10.1186/cc8911, 2887140, 20230641.
12. Hillenbrand A, Knippschild U, Weiss M, Schrezenmeier H, Henne-Bruns D, Huber-Lang M, Wolf AM. Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients. BMC Surg 2010, 10:26. 10.1186/1471-2482-10-26, 2944119, 20825686.
13. Langouche L, Vander Perre S, Frystyk J, Flyvbjerg A, Hansen TK, Van den Berghe G. Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin. Crit Care 2009, 13:R112. 10.1186/cc7956, 2750156, 19589139.
14. Esmon CT, Taylor FB, Snow TR. Inflammation and coagulation: Linked processes potentially regulated through a common pathway mediated by protein c. Thromb Haemost 1991, 66:160-165.
15. Joyce DE, Grinnell BW. Recombinant human activated protein c attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappab. Crit Care Med 2002, 30:S288-293. 10.1097/00003246-200205001-00019, 12004250.
16. Cheng T, Liu D, Griffin JH, Fernandez JA, Castellino F, Rosen ED, Fukudome K, Zlokovic BV. Activated protein c blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med. 2003, 9:338-342. 10.1038/nm826, 12563316.
17. Brueckmann M, Huhle G, Max M. [mechanisms of action of recombinant human activated protein c]. Anaesthesist 2006, 55(Suppl 1):5-15.
18. Brueckmann M, Hoffmann U, De Rossi L, Weiler HM, Liebe V, Lang S, Kaden JJ, Borggrefe M, Haase KK, Huhle G. Activated protein c inhibits the release of macrophage inflammatory protein-1-alpha from thp-1 cells and from human monocytes. Cytokine 2004, 26:106-113. 10.1016/j.cyto.2004.01.004, 15135804.
19. Brueckmann M, Hoffmann U, Dvortsak E, Lang S, Kaden JJ, Borggrefe M, Haase KK. Drotrecogin alfa (activated) inhibits nf-kappa b activation and mip-1-alpha release from isolated mononuclear cells of patients with severe sepsis. Inflamm Res 2004, 53:528-533. 10.1007/s00011-004-1291-z, 15597147.
20. Brueckmann M, Horn S, Lang S, Fukudome K, Schulze Nahrup A, Hoffmann U, Kaden JJ, Borggrefe M, Haase KK, Huhle G. Recombinant human activated protein c upregulates cyclooxygenase-2 expression in endothelial cells via binding to endothelial cell protein c receptor and activation of protease-activated receptor-1. Thromb Haemost 2005, 93:743-750.
21. Brueckmann M, Marx A, Weiler HM, Liebe V, Lang S, Kaden JJ, Zieger W, Borggrefe M, Huhle G, Konstantin Haase K. Stabilization of monocyte chemoattractant protein-1-mrna by activated protein c. Thromb Haemost 2003, 89:149-160.
22. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative rt-pcr data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3:RESEARCH0034. 126239, 12184808.
23. Schmittgen TD, Livak KJ. Analyzing real-time pcr data by the comparative c(t) method. Nat Protoc 2008, 3:1101-1108. 10.1038/nprot.2008.73, 18546601.
24. Livak KJ. Comparative Ct method. ABI Prism 7700 Sequence Detection System. User Bulletin no. 2. PE Applied Biosystems. 1997,
25. PCR primer, a laboratory manual 2003, Cold Spring Harbor Laboratory Press, New York, Dieffenbach CW, Dveksler GS, 2.
26. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Apache ii: A severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
27. Hughes M. Recombinant human activated protein c. Int J Antimicrob Agents 2006, 28:90-94. 10.1016/j.ijantimicag.2006.05.021, 16837170.
28. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ. Efficacy and safety of recombinant human activated protein c for severe sepsis. N Engl J Med 2001, 344:699-709. 10.1056/NEJM200103083441001, 11236773.
29. Quantikine® human leptin Immunoassay 2009, R&D Systems Inc, Minneapolis, USA, internet-address: http://www.rndsystems.com/pdf/dlp00.pdf, Quantikine®.
30. Fawcett RL, Waechter AS, Williams LB, Zhang P, Louie R, Jones R, Inman M, Huse J, Considine RV. Tumor necrosis factor-alpha inhibits leptin production in subcutaneous and omental adipocytes from morbidly obese humans. J Clin Endocrinol Metab 2000, 85:530-535. 10.1210/jc.85.2.530, 10690850.
31. Granowitz EV. Transforming growth factor-beta enhances and pro-inflammatory cytokines inhibit ob gene expression in 3 t3-l1 adipocytes. Biochem Biophys Res Commun 1997, 240:382-385. 10.1006/bbrc.1997.7663, 9388486.
32. Laharrague P, Truel N, Fontanilles AM, Corberand JX, Penicaud L, Casteilla L. Regulation by cytokines of leptin expression in human bone marrow adipocytes. Horm Metab Res 2000, 32:381-385. 10.1055/s-2007-978658, 11069201.
33. Yamaguchi M, Murakami T, Tomimatsu T, Nishio Y, Mitsuda N, Kanzaki T, Kurachi H, Shima K, Aono T, Murata Y. Autocrine inhibition of leptin production by tumor necrosis factor-alpha (tnf-alpha) through tnf-alpha type-i receptor in vitro. Biochem Biophys Res Commun 1998, 244:30-34. 10.1006/bbrc.1998.8199, 9514868.
34. Gottschling-Zeller H, Birgel M, Scriba D, Blum WF, Hauner H. Depot-specific release of leptin from subcutaneous and omental adipocytes in suspension culture: Effect of tumor necrosis factor-alpha and transforming growth factor-beta1. Eur J Endocrinol 1999, 141:436-442. 10.1530/eje.0.1410436, 10526261.
35. Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 2001, 175:81-92. 10.1016/S0303-7207(01)00394-X, 11325518.
36. Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet DJ, Flier JS, Lowell BB, Fraker DL, Alexander HR. Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia. J Exp Med. 1997, 185:171-175. 10.1084/jem.185.1.171, 2196098, 8996253.
37. Arnalich F, Lopez J, Codoceo R, Jim nez M, Madero R, Montiel C. Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock. J Infect Dis 1999, 180:908-911. 10.1086/314963, 10438392.
38. Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P, Chrousos GP. Plasma leptin levels are increased in survivors of acute sepsis: Associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 1998, 83:280-283. 10.1210/jc.83.1.280, 9435456.
39. Maruna P, Gurlich R, Frasko R, Haluzik M. Serum leptin levels in septic men correlate well with c-reactive protein (crp) and tnf-alpha but not with bmi. Physiol Res 2001, 50:589-594.
40. Nylen ES, Alarifi AA. Humoral markers of severity and prognosis of critical illness. Best Pract Res Clin Endocrinol Metab. 2001, 15:553-573. 10.1053/beem.2001.0169, 11800523.
41. Torpy DJ, Bornstein SR, Chrousos GP. Leptin and interleukin-6 in sepsis. Horm Metab Res 1998, 30:726-729. 10.1055/s-2007-978967, 9930630.
42. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J 1998, 12:57-65.
43. Behnes M, Brueckmann M, Liebe V, Liebetrau C, Lang S, Putensen C, Borggrefe M, Hoffmann U. Levels of oxidized low-density lipoproteins are increased in patients with severe sepsis. J Crit Care. 2008, 23:537-541. 10.1016/j.jcrc.2008.09.002, 19056019.
44. Behnes M, Brueckmann M, Wiessner M, Kettenmann E, Liebetrau C, Lang S, Putensen C, Borggrefe M, Hoffmann U. Time-course of neopterin levels in patients suffering from severe sepsis treated with and without drotrecogin-alpha (activated). Scand J Infect Dis 2008, 40:503-508. 10.1080/00365540701808978, 18584538.
45. Behnes M, Brueckmann M, Lang S, Putensen C, Saur J, Borggrefe M, Hoffmann U. Alterations of adiponectin in the course of inflammation and severe sepsis. Shock 2012, 38:243-248. 10.1097/SHK.0b013e318261e0dc, 22744305.
46. Shapiro NI, Khankin EV, Van Meurs M, Shih SC, Lu S, Yano M, Castro PR, Maratos-Flier E, Parikh SM, Karumanchi SA, Yano K. Leptin exacerbates sepsis-mediated morbidity and mortality. J Immunol 185:517-524.